Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
By inhibiting glucagon release, GLP-1 helps to prevent an excessive rise in blood sugar levels after meals
10.1074/jbc.M114.549634[Epub ahead of print]
I don't snack as much as I used to
We will provide a full breakdown of any additional costs so you can make an informed decision
Patients: A total of 9650 adult patients with established CV disease without CKD (56.7%), CKD only (13%), or both CV disease and CKD (27%) were randomized 1:1 to receive semaglutide tablets 14 mg (n=4825) or placebo (n=4825) once daily, both in addition to standard-of-care treatments for glycemic control and CV risk factors including blood pressure medication, lipid-lowering agents, and antiplatelet/anticoagulant therapy
US$ 21.81
US$ 24.34
US$ 27.02
US$ 29.02
